-
1
-
-
33644855102
-
American gastroenterological association institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
-
DOI 10.1053/j.gastro.2006.01.047, PII S0016508506000734
-
G.R. Lichtenstein, M.T. Abreu, and R. Cohen American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease Gastroenterology 130 2006 935 939 (Pubitemid 43374542)
-
(2006)
Gastroenterology
, vol.130
, Issue.3
, pp. 935-939
-
-
Lichtenstein, G.R.1
Abreu, M.T.2
Cohen, R.3
Tremaine, W.4
-
2
-
-
35649016260
-
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008
-
D.E. Furst, E.C. Keystone, and B. Kirkham Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008 Ann Rheum Dis 67 suppl 3 2008 iii2 iii25
-
(2008)
Ann Rheum Dis
, vol.67
, Issue.SUPPL. 3
-
-
Furst, D.E.1
Keystone, E.C.2
Kirkham, B.3
-
3
-
-
70149109879
-
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: A randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
-
A.M. Alousi, D.J. Weisdorf, and B.R. Logan Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network Blood 114 2009 511 517
-
(2009)
Blood
, vol.114
, pp. 511-517
-
-
Alousi, A.M.1
Weisdorf, D.J.2
Logan, B.R.3
-
4
-
-
62549084077
-
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma
-
S.E. Wenzel, P.J. Barnes, and E.R. Bleecker A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma Am J Respir Crit Care Med 179 2009 549 558
-
(2009)
Am J Respir Crit Care Med
, vol.179
, pp. 549-558
-
-
Wenzel, S.E.1
Barnes, P.J.2
Bleecker, E.R.3
-
5
-
-
33646696885
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
-
DOI 10.1001/jama.295.19.2275
-
T. Bongartz, A.J. Sutton, and M.J. Sweeting Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 295 2006 2275 2285 (Pubitemid 43736578)
-
(2006)
Journal of the American Medical Association
, vol.295
, Issue.19
, pp. 2275-2285
-
-
Bongartz, T.1
Sutton, A.J.2
Sweeting, M.J.3
Buchan, I.4
Matteson, E.L.5
Montori, V.6
-
6
-
-
0028988635
-
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report
-
N.L. Bartlett, S.A. Rosenberg, and R.T. Hoppe Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report J Clin Oncol 13 1995 1080 1088
-
(1995)
J Clin Oncol
, vol.13
, pp. 1080-1088
-
-
Bartlett, N.L.1
Rosenberg, S.A.2
Hoppe, R.T.3
-
7
-
-
27744520447
-
Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
-
DOI 10.1136/ard.2004.033241
-
J. Askling, C.M. Fored, and E. Baecklund Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists Ann Rheum Dis 64 2005 1414 1420 (Pubitemid 41623850)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.10
, pp. 1414-1420
-
-
Askling, J.1
Fored, C.M.2
Baecklund, E.3
Brandt, L.4
Backlin, C.5
Ekbom, A.6
Sundstrom, C.7
Bertilsson, L.8
Coster, L.9
Geborek, P.10
Jacobsson, L.T.11
Lindblad, S.12
Lysholm, J.13
Rantapaa-Dahlqvist, S.14
Saxne, T.15
Klareskog, L.16
Feltelius, N.17
-
8
-
-
0036900501
-
Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration
-
DOI 10.1002/art.10679
-
S.L. Brown, M.H. Greene, and S.K. Gershon Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration Arthritis Rheum 46 2002 3151 3158 (Pubitemid 35453523)
-
(2002)
Arthritis and Rheumatism
, vol.46
, Issue.12
, pp. 3151-3158
-
-
Brown, S.L.1
Greene, M.H.2
Gershon, S.K.3
Edwards, E.T.4
Braun, M.M.5
-
9
-
-
36148986073
-
Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis
-
DOI 10.1007/s00296-007-0391-9
-
K. Aksu, A. Donmez, and Y. Ertan Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis Rheumatol Int 28 2007 185 187 (Pubitemid 350105860)
-
(2007)
Rheumatology International
, vol.28
, Issue.2
, pp. 185-187
-
-
Aksu, K.1
Donmez, A.2
Ertan, Y.3
Keser, G.4
Inal, V.5
Oder, G.6
Tombuloglu, M.7
Kabasakal, Y.8
Doganavsargil, E.9
-
10
-
-
33745361098
-
Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: Case report and review of the literature
-
DOI 10.1080/00365520500529629, PII V5631141731620
-
M. Bai, K.H. Katsanos, and M. Economou Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature Scand J Gastroenterol 41 2006 866 869 (Pubitemid 43941249)
-
(2006)
Scandinavian Journal of Gastroenterology
, vol.41
, Issue.7
, pp. 866-869
-
-
Bai, M.1
Katsanos, K.2
Economou, M.3
Kamina, S.4
Balli, C.5
Briasoulis, E.6
Kappas, A.7
Agnantis, N.8
Tsianos, E.9
-
11
-
-
0032738644
-
The relationship between infliximab treatment and lymphoma in Crohn's disease
-
S.J. Bickston, G.R. Lichtenstein, and K.O. Arseneau The relationship between infliximab treatment and lymphoma in Crohn's disease Gastroenterology 117 1999 1433 1437
-
(1999)
Gastroenterology
, vol.117
, pp. 1433-1437
-
-
Bickston, S.J.1
Lichtenstein, G.R.2
Arseneau, K.O.3
-
12
-
-
49049094614
-
Hodgkin's lymphoma associated with anti-TNF use in juvenile idiopathic arthritis: Supplemental case report
-
L. Imundo Hodgkin's lymphoma associated with anti-TNF use in juvenile idiopathic arthritis: supplemental case report J Rheumatol 35 2008 1681
-
(2008)
J Rheumatol
, vol.35
, pp. 1681
-
-
Imundo, L.1
-
13
-
-
77950394280
-
How i treat EBV lymphoproliferation
-
H.E. Heslop How I treat EBV lymphoproliferation Blood 114 2009 4002 4008
-
(2009)
Blood
, vol.114
, pp. 4002-4008
-
-
Heslop, H.E.1
-
14
-
-
0035025775
-
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients
-
D.E. Tsai, C.L. Hardy, and J.E. Tomaszewski Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients Transplantation 71 2001 1076 1088 (Pubitemid 32448822)
-
(2001)
Transplantation
, vol.71
, Issue.8
, pp. 1076-1088
-
-
Tsai, D.E.1
Hardy, C.L.2
Tomaszewski, J.E.3
Kotloff, R.M.4
Oltoff, K.M.5
Somer, B.G.6
Schuster, S.J.7
Porter, D.L.8
Montone, K.T.9
Stadtmauer, E.A.10
-
15
-
-
0033610627
-
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic Organized International Consensus Development Meeting
-
C.V. Paya, J.J. Fung, and M.A. Nalesnik Epstein-Barr virus-induced posttransplant lymphoproliferative disorders ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting Transplantation 68 1999 1517 1525
-
(1999)
Transplantation
, vol.68
, pp. 1517-1525
-
-
Paya, C.V.1
Fung, J.J.2
Nalesnik, M.A.3
-
16
-
-
49249097559
-
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder
-
L.J. Swinnen, M. LeBlanc, and T.M. Grogan Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder Transplantation 86 2008 215 222
-
(2008)
Transplantation
, vol.86
, pp. 215-222
-
-
Swinnen, L.J.1
Leblanc, M.2
Grogan, T.M.3
-
17
-
-
0033781798
-
Hodgkin's disease and the Epstein-Barr virus
-
K.J. Flavell, and P.G. Murray Hodgkin's disease and the Epstein-Barr virus Mol Pathol 53 2000 262 269
-
(2000)
Mol Pathol
, vol.53
, pp. 262-269
-
-
Flavell, K.J.1
Murray, P.G.2
-
18
-
-
54249168688
-
AIDS-related malignancies: State of the art and therapeutic challenges
-
J.P. Spano, D. Costagliola, and C. Katlama AIDS-related malignancies: state of the art and therapeutic challenges J Clin Oncol 26 2008 4834 4842
-
(2008)
J Clin Oncol
, vol.26
, pp. 4834-4842
-
-
Spano, J.P.1
Costagliola, D.2
Katlama, C.3
-
19
-
-
0025908226
-
AIDS-associated non-Hodgkin lymphoma
-
V. Beral, T. Peterman, and R. Berkelman AIDS-associated non-Hodgkin lymphoma Lancet 337 1991 805 809
-
(1991)
Lancet
, vol.337
, pp. 805-809
-
-
Beral, V.1
Peterman, T.2
Berkelman, R.3
-
20
-
-
0035760292
-
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy
-
O. Kirk, C. Pedersen, and A. Cozzi-Lepri Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy Blood 98 2001 3406 3412
-
(2001)
Blood
, vol.98
, pp. 3406-3412
-
-
Kirk, O.1
Pedersen, C.2
Cozzi-Lepri, A.3
-
21
-
-
33845237838
-
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
-
DOI 10.1182/blood-2006-05-024109
-
R.J. Biggar, E.S. Jaffe, and J.J. Goedert Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS Blood 108 2006 3786 3791 (Pubitemid 44864560)
-
(2006)
Blood
, vol.108
, Issue.12
, pp. 3786-3791
-
-
Biggar, R.J.1
Jaffe, E.S.2
Goedert, J.J.3
Chaturvedi, A.4
Pfeiffer, R.5
Engels, E.A.6
-
22
-
-
13244273520
-
Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART)
-
DOI 10.1080/10428190400015733
-
T. Wolf, H.R. Brodt, and S. Fichtlscherer Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART) Leuk Lymphoma 46 2005 207 215 (Pubitemid 40185950)
-
(2005)
Leukemia and Lymphoma
, vol.46
, Issue.2
, pp. 207-215
-
-
Wolf, T.1
Brodt, H.-R.2
Fichtlscherer, S.3
Mantzsch, K.4
Hoelzer, D.5
Helm, E.B.6
Mitrou, P.S.7
Chow, K.U.8
-
23
-
-
0035072134
-
Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antireroviral therapy (HAART)
-
K.U. Chow, P.S. Mitrou, and K. Geduldig Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART) Leuk Lymphoma 41 2001 105 116 (Pubitemid 32294194)
-
(2001)
Leukemia and Lymphoma
, vol.41
, Issue.1-2
, pp. 105-116
-
-
Chow, K.U.1
Mitrou, P.S.2
Geduldig, K.3
Helm, E.B.4
Hoelzer, D.5
Brodt, H.-R.6
|